Skip to main content
Premium Trial:

Request an Annual Quote

BGI, UC Davis Building Sequencing Facility

NEW YORK (GenomeWeb News) – Building on an earlier partnership, BGI and the University of California, Davis today announced a deal to create a sequencing facility at the school.

A facility is being established for immediate use on the UC Davis Health System campus in Sacramento, while a permanent [email protected] Davis Joint Genome Center encompassing about 10,000 square feet is planned.

The facility will support research and collaborations and "leverage existing strengths" across the university in human and animal health and medicine, food safety and security, biology, and the environment, the partners said in a statement. About 20 new jobs are being created as a result of the facility's creation, with that figure rising to 200 jobs when it is completely up and running.

The deal provides UC Davis faculty and students access to the capabilities and expertise of BGI, and in return BGI will have access to the university's diverse resources and expertise in education and research, "especially in biology, human and veterinary medicine, agriculture, and the environment," the partners said.

"UC Davis brings to this partnership phenomenal faculty conducting cutting-edge research on food, health, energy, and the environment, while BGI is a world leader in genome sequencing and analysis," UC Davis Chancellor Linda Katehi said in a statement. "Together as partners, UC Davis and BGI will be able to take on the biggest challenges in biology, medicine, and the environment – right here in Sacramento."

BGI and UC Davis said this past June that they would share resources and conduct large-scale sequencing and functional genomics programs on a broad array of research areas.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.